PROGESTERONE ORAL DRUG DELIVERY SYSTEM

Details for Australian Patent Application No. 2002242339 (hide)

Owner WATSON PHARMACEUTICALS, INC.

Inventors TAN, Domingo, Y.

Pub. Number AU-A-2002242339

PCT Pub. Number WO2003/077923

Filing date 14 March 2002

Wipo publication date 29 September 2003

International Classifications

A61K 031/565 - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 031/57 - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

Event Publications

6 November 2003 Application Open to Public Inspection

  Published as AU-A-2002242339

3 August 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002242340-Acquisition/distribution layer and method of making same

2002242338-MULTIPLE COMPARTMENT POUCH WITH MULTIPLE DISPENSING CHANNELS